BIOVENTUS INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
BIOVENTUS INC. (BVS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $4.03 per share for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-05
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-28 was $4.00, a 10.51% decline year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-29 was $4.47, a 13.71% decline year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-30 was $5.18.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-04-02 was $8.73.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $4.70, a 34.54% decline from fiscal 2024.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $7.18, a 167.91% increase from fiscal 2023.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $2.68, a 57.32% decline from fiscal 2022.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $6.28, a 4.67% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-27 | $4.03 10-Q · filed 2026-08-05 | |||
| 2026-03-28 | $4.00 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $4.70 10-K · filed 2026-03-05 | |||
| 2025-09-27 | $4.72 10-Q · filed 2025-11-04 | |||
| 2025-06-28 | $5.24 10-Q · filed 2025-08-06 | |||
| 2025-03-29 | $4.47 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $7.18 10-K · filed 2026-03-05 | |||
| 2024-09-28 | $6.28 10-Q · filed 2024-11-05 | |||
| 2024-06-29 | $5.21 10-Q · filed 2024-08-06 | |||
| 2024-03-30 | $5.18 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $2.68 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $2.69 10-Q · filed 2023-11-07 | |||
| 2022-12-31 | $6.28 10-K · filed 2024-03-12 | |||
| 2022-10-01 | $6.69 10-Q · filed 2022-11-21 | |||
| 2022-07-02 | $7.12 10-Q · filed 2022-08-12 | |||
| 2022-04-02 | $8.73 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $6.00 10-K · filed 2023-03-31 |